Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwanghee Lee

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2023
BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non-Small Cell Lung CancerSun Min Lim, Toshio Fujino, Chulwon Kim, et al.
Plos Biology|August 8, 2008
TSCOT+ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentationSejin Ahn, Gwanghee Lee, Soo Jung Yang, et al.
Journal for Immunotherapy of Cancer|March 3, 2025
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancerHyung-Don Kim, Seyoung Jung, Yeong Hak Bang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2023
BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non-Small Cell Lung CancerSun Min Lim, Toshio Fujino, Chulwon Kim, et al.
Plos Biology|August 8, 2008
TSCOT+ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentationSejin Ahn, Gwanghee Lee, Soo Jung Yang, et al.
Journal for Immunotherapy of Cancer|March 3, 2025
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancerHyung-Don Kim, Seyoung Jung, Yeong Hak Bang, et al.
Pageof 2